EP2663561

Nýjar heterósýklískar afleiður og notkun þeirra við að meðhöndla taugaraskanir

  • Status:
    EP Einkaleyfi fallið úr gildi
  • EP appl. date:
    11.1.2012
  • EP published:
    16.3.2016
  • EP application number:
    12700390.3
  • Max expiry date:
    10.1.2032
  • Expiry date:
    10.1.2020
  • Title:
    NOVEL HETEROCYCLIC DERIVATIVES AND THEIR USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS

Timeline

Today
11.1.2012EP application
16.3.2016EP Publication
23.5.2016Translation submitted
15.6.2016Registration published
10.1.2020Expires

Owner

  • Name:
    Novartis AG
  • Address:
    Lichtstrasse 35, 4056, Basel, CH

Inventor

  • Name:
    BADIGER, Sangamesh
  • Address:
    Karnataka 560 100, IN
  • Name:
    CHEBROLU, Murali
  • Address:
    Karnataka 560 100, IN
  • Name:
    HURTH, Konstanze
  • Address:
    Basel, CH
  • Name:
    JACQUIER, Sébastien
  • Address:
    Basel, CH
  • Name:
    LUEOEND, Rainer Martin
  • Address:
    Basel, CH
  • Name:
    MACHAUER, Rainer
  • Address:
    Basel, CH
  • Name:
    RUEEGER, Heinrich
  • Address:
    Basel, CH
  • Name:
    TINTELNOT-BLOMLEY, Marina
  • Address:
    Basel, CH
  • Name:
    VEENSTRA, Siem Jacob
  • Address:
    Basel, CH
  • Name:
    VOEGTLE, Markus
  • Address:
    Basel, CH

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113, Reykjavík,

Priority

  • Number:
    DE00772011
  • Date:
    13.1.2011
  • Country:
    IN
  • Number:
    201161534591 P
  • Date:
    14.9.2011
  • Country:
    US

Classification

  • Categories:
    C07D 413/14, C07D 471/04, C07D 487/04, A61K 31/5377, A61P 25/00

Annual fees

Number

Paid

Expires

Payer

Number: 6

Paid: 28.12.2016

Expires: 10.1.2018

Payer: Árnason Faktor

Number: 7

Paid: 29.12.2017

Expires: 10.1.2019

Payer: Árnason Faktor

Number: 8

Paid: 2.1.2019

Expires: 10.1.2020

Payer: Árnason Faktor

Upload documents